Aileron Therapeutics, Inc.
ALRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,581 | -$6,822 | -$5,501 | -$40,981 |
| Dep. & Amort. | $0 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$1,554 |
| Stock-Based Comp. | $1,447 | $256 | $264 | $133 |
| Change in WC | $791 | $938 | $0 | $0 |
| Other Non-Cash | -$205 | -$791 | -$938 | $37,590 |
| Operating Cash Flow | -$3,548 | -$6,418 | -$6,175 | -$4,812 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$370 | $737 | -$7,326 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,900 | $4,712 | $738 | $7,327 |
| Financing Cash Flow | $1,900 | $4,712 | $738 | $1 |
| Forex Effect | -$26 | $0 | $0 | -$1 |
| Net Chg. in Cash | -$1,674 | -$1,706 | -$5,437 | -$4,812 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,722 | $7,428 | $12,865 | $17,677 |
| End Cash | $4,048 | $5,722 | $7,428 | $12,865 |
| Free Cash Flow | -$3,548 | -$6,418 | -$6,175 | -$4,812 |